Sreyan Chowdhury

Title: Sreyan Chowdhury: Innovator in Cancer Treatment

Introduction

Sreyan Chowdhury is a notable inventor based in New York, NY (US). He has made significant contributions to the field of cancer treatment through his innovative work in programmable bacteria. His research focuses on developing advanced therapeutic methods to combat cancer effectively.

Latest Patents

Sreyan Chowdhury holds 1 patent for his invention titled "Programmable bacteria for the treatment of cancer." This patent discloses programmable bacteria designed for tumor-targeted immunotherapeutic delivery. The bacteria feature at least one synchronized lysis circuit contained in a single operon, which can be engineered to produce anti-cancer therapeutic agents. These agents include nanobodies against immune checkpoint inhibitors, toxins, tumor antigens, cytokines, and chemokines. The patent also outlines methods for curing and treating cancer using these programmable bacteria.

Career Highlights

Throughout his career, Sreyan Chowdhury has worked with prestigious institutions, including Columbia University and the United States Department of Health and Human Services. His work has been instrumental in advancing cancer treatment methodologies and enhancing therapeutic delivery systems.

Collaborations

Sreyan has collaborated with notable colleagues such as Tal Danino and Nicholas Arpaia. These partnerships have contributed to the development and refinement of his innovative approaches to cancer treatment.

Conclusion

Sreyan Chowdhury's work in programmable bacteria represents a significant advancement in cancer therapy. His innovative approach has the potential to transform treatment methodologies and improve patient outcomes.